Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

por Lee, Cheol-Hyung, Lee, Yun Bin, Kim, Minseok Albert, Jang, Heejoon, Oh, Hyunwoo, Kim, Sun Woong, Cho, Eun Ju, Lee, Kyung-Hun, Lee, Jeong-Hoon, Yu, Su Jong, Yoon, Jung-Hwan, Kim, Tae-You, Kim, Yoon Jun
Publicado 2020

Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study

por Yoon, Jun Sik, Sinn, Dong Hyun, Lee, Jeong-Hoon, Kim, Hwi Young, Lee, Cheol-Hyung, Kim, Sun Woong, Lee, Hyo Young, Nam, Joon Yeul, Chang, Young, Lee, Yun Bin, Cho, Eun Ju, Yu, Su Jong, Kim, Hyo-Cheol, Chung, Jin Wook, Kim, Yoon Jun, Yoon, Jung-Hwan
Publicado 2019

Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

por Chung, Sung Won, Park, Min Kyung, Cho, Young Youn, Park, Youngsu, Lee, Cheol-Hyung, Oh, Hyunwoo, Jang, Heejoon, Kim, Minseok Albert, Kim, Sun Woong, Nam, Joon Yeul, Lee, Yun Bin, Cho, Eun Ju, Yu, Su Jong, Kim, Hyo-Cheol, Kim, Yoon Jun, Chung, Jin Wook, Yoon, Jung-Hwan, Lee, Jeong-Hoon
Publicado 2021